My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Moderna, Inc. - Common Stock (NQ:MRNA)

34.23 +0.37 (+1.09%)

Streaming Delayed Price Updated: 10:31 AM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer ↗

October 10, 2024

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could...

Via Benzinga

(MRNA) - Analyzing Moderna's Short Interest ↗

October 08, 2024

Via Benzinga

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 08, 2024

From The Schall Law Firm

Via Business Wire

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

October 08, 2024

Via Benzinga

Abbas Hussain Joins Moderna's Board of Directors

October 02, 2024

Via ACCESSWIRE

Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today ↗

September 24, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 07, 2024

Via Benzinga

Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio? ↗

October 06, 2024

Eleven large-cap stocks were worst performers last week. Decline in Stars performance and sales, regulations and supply issues caused the drop.

Via Benzinga

MRNA Deadline: Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights

October 05, 2024

From Rosen Law Firm

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

October 04, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer ↗

October 04, 2024

Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.

Via Investor's Business Daily

IMPORTANT MRNA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

October 03, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine ↗

October 03, 2024

Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible...

Via Benzinga

Topics Intellectual Property

Is It Time to Buy September's Worst-Performing S&P 500 Stocks? ↗

October 02, 2024

Could rebounds be in store for these beaten-down stocks?

Via The Motley Fool

Topics Stocks

The Covid Era Tech Promises To Reinvent Cancer Treatment ↗

October 01, 2024

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

September 30, 2024

Via ACCESSWIRE

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 30, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

September 30, 2024

Via ACCESSWIRE

3 Surprisingly Underrated Stocks to Buy Right Now ↗

September 28, 2024

These stocks might look like bad picks. But appearances can be deceiving.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 25, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

September 24, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Top 3 Health Care Stocks That May Explode This Month ↗

September 23, 2024

Via Benzinga

2 Beaten-Down Stocks to Buy and Hold for a Decade ↗

September 23, 2024

These innovative companies have the tools to rebound.

Via The Motley Fool

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 23, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 21, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Pfizer Advances On Its Cancer Journey ↗

September 20, 2024

On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024...

Via Benzinga

Down 13% in 1 Day, Is Moderna Stock in Trouble? ↗

September 20, 2024

There's no hope of it recovering to its prior heights anytime soon.

Via The Motley Fool

3 Beaten-Down Stocks Ready for a Comeback

September 19, 2024

if you're looking for a way to escape the market volatility, here are three stocks that are trading near their 52-week lows with solid catalysts for growth

Via MarketBeat

Topics Economy

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks ↗

September 19, 2024

This strategic play will take time to pay off, but it could keep growth going.

Via The Motley Fool

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.